Skip to main content
Top
Published in: Inflammation Research 2/2018

01-02-2018 | Original Research Paper

Diet-induced obesity leads to pro-inflammatory alterations to the vitreous humour of the eye in a rat model

Authors: Kelsey H. Collins, Walter Herzog, Raylene A. Reimer, Carol R. Reno, Bryan J. Heard, David A. Hart

Published in: Inflammation Research | Issue 2/2018

Login to get access

Abstract

Objective and design

The purpose of this study was to investigate if diet-induced obesity (DIO) and subsequent low-level systemic inflammation would result in local increases in pro-inflammatory mediators in the vitreous humour (VH) of the eyes of rats.

Methods

Sixteen male Sprague–Dawley rats were fed a high-fat/high-sucrose (n = 9) or chow control-diet (n = 7) for 12-weeks. RT-qPCR was conducted on RNA from VH cells and a 27-plex Luminex® Assay was conducted on VH fluid and serum.

Results

Increased protein levels for IL-1β, IL-6, and IL-18 in both serum and VH fluid were observed. VH protein levels for IL-13 and IL-17 were also increased. All mediators significantly increased in VH fluid were also positively correlated with percent body fat. Increased mRNA levels in VH cells for an oxidative stress molecule were accompanied by decreased mRNA levels for an antioxidant scavenger, suggesting an antioxidant/oxidant imbalance in the VH with DIO. In addition, decreased mRNA levels for TRAIL, FAS-L and TGF-β, molecules associated with immune privilege, were also significantly depressed.

Conclusions

DIO-related metabolic disturbances disrupt VH homeostasis in a manner that reflects development of a pro-inflammatory environment. Prolonged exposure to such an environment may lead to overt pathologies with compromised eye function.
Literature
3.
go back to reference Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: executive summary. Crit Pathw Cardiol. 2005;4:198–203. http://www.ncbi.nlm.nih.gov/pubmed/18340209. Accessed 14 Dec 2013. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: executive summary. Crit Pathw Cardiol. 2005;4:198–203. http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​18340209. Accessed 14 Dec 2013.
6.
8.
go back to reference Collins KH, Paul HA, Reimer RA, Seerattan R-A, Hart DA, Herzog W. Relationship between inflammation, the gut microbiota, and metabolic osteoarthritis development: studies in a rat model. Osteoarthr Cartil. 2015;23:1989–98.CrossRefPubMed Collins KH, Paul HA, Reimer RA, Seerattan R-A, Hart DA, Herzog W. Relationship between inflammation, the gut microbiota, and metabolic osteoarthritis development: studies in a rat model. Osteoarthr Cartil. 2015;23:1989–98.CrossRefPubMed
9.
go back to reference Collins KH, Hart DA, Reimer RA, Seerattan RA, Herzog W. Response to diet-induced obesity produces time-dependent induction and progression of metabolic osteoarthritis in rat knees. J Orthop Res. 2016;34:1010–8.CrossRefPubMed Collins KH, Hart DA, Reimer RA, Seerattan RA, Herzog W. Response to diet-induced obesity produces time-dependent induction and progression of metabolic osteoarthritis in rat knees. J Orthop Res. 2016;34:1010–8.CrossRefPubMed
13.
go back to reference Sonoda K, Nakamura T, Young HA, Hart D, Carmeliet P, Stein-streilein J. NKT cell-derived urokinase-type plasminogen activator promotes peripheral tolerance associated with eye. J Immunol. 2007;1–8. Sonoda K, Nakamura T, Young HA, Hart D, Carmeliet P, Stein-streilein J. NKT cell-derived urokinase-type plasminogen activator promotes peripheral tolerance associated with eye. J Immunol. 2007;1–8.
15.
go back to reference Stein-Streilein J, Streilein JW. Anterior chamber associated immune deviation (ACAID): regulation, biological relevance, and implications for therapy. Int Rev Immunol. 2002;21:123–52. doi:10.1080/08830180212066. Stein-Streilein J, Streilein JW. Anterior chamber associated immune deviation (ACAID): regulation, biological relevance, and implications for therapy. Int Rev Immunol. 2002;21:123–52. doi:10.​1080/​08830180212066.
19.
go back to reference Collins KH, Hart D, Smith I, Issler A, Reimer R, Seerattan R, et al. Acute and chronic changes in rat soleus muscle after high-fat high-sucrose diet. Physiol Rep. 2017. Collins KH, Hart D, Smith I, Issler A, Reimer R, Seerattan R, et al. Acute and chronic changes in rat soleus muscle after high-fat high-sucrose diet. Physiol Rep. 2017.
21.
27.
40.
go back to reference Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2011;107:1058–70.CrossRef Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2011;107:1058–70.CrossRef
44.
go back to reference Amadi-Obi A, Yu C-R, Liu X, Mahdi RM, Clarke GL, Nussenblatt RB, et al. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med. 2007;13:711–8. doi:10.1038/nm1585.CrossRefPubMed Amadi-Obi A, Yu C-R, Liu X, Mahdi RM, Clarke GL, Nussenblatt RB, et al. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med. 2007;13:711–8. doi:10.​1038/​nm1585.CrossRefPubMed
45.
go back to reference Horai R, Zárate-Bladés CR, Dillenburg-Pilla P, Chen J, Kielczewski JL, Silver PB, et al. Microbiota-dependent activation of an autoreactive T cell receptor provokes autoimmunity in an immunologically privileged site. Immunity. 2015;43:343–53. http://www.ncbi.nlm.nih.gov/pubmed/26287682. Accessed 9 Apr 2017. Horai R, Zárate-Bladés CR, Dillenburg-Pilla P, Chen J, Kielczewski JL, Silver PB, et al. Microbiota-dependent activation of an autoreactive T cell receptor provokes autoimmunity in an immunologically privileged site. Immunity. 2015;43:343–53. http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​26287682. Accessed 9 Apr 2017.
Metadata
Title
Diet-induced obesity leads to pro-inflammatory alterations to the vitreous humour of the eye in a rat model
Authors
Kelsey H. Collins
Walter Herzog
Raylene A. Reimer
Carol R. Reno
Bryan J. Heard
David A. Hart
Publication date
01-02-2018
Publisher
Springer International Publishing
Published in
Inflammation Research / Issue 2/2018
Print ISSN: 1023-3830
Electronic ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-017-1102-y

Other articles of this Issue 2/2018

Inflammation Research 2/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.